200
Participants
Start Date
November 20, 2023
Primary Completion Date
May 1, 2026
Study Completion Date
December 31, 2026
continuous blood glucose monitoring in a subset of women (n=25) in the early monitoring group.
To continuously monitor blood glucose from baseline to 28 weeks to determine if if there is hyperglycaemia in a subset of women (n=25)
Collection of urine, maternal blood at baseline and 28 weeks in a subset of women (n=25)
To study maternal metabolome
Collection of umbilical cord blood, placental samples and cord tissue in a subset of women (n=25)
To study mesenchymal stem cell differentiation, change in fetal epigenetic and placental signalling pathways.
Maternal and neonatal outcome data collection for all women in the study
Data for maternal and neonatal outcomes will be collected
RECRUITING
Chelsea and Westminster Trust, London
Collaborators (1)
Bold insight
UNKNOWN
DexCom, Inc.
INDUSTRY
Imperial College London
OTHER